Sphingosine-1-phosphate receptor (S1PR) (S1PR)

Sphingosine-1-phosphate receptors (S1PRs) are a family of five G protein-coupled receptors (S1PR1–5) that mediate the biological effects of the signaling lipid sphingosine-1-phosphate [IUPHAR/BPS Guide to Pharmacology]. These receptors are critical for regulating lymphocyte trafficking, particularly S1PR1, which is essential for the egress of T and B cells from lymphoid organs into the blood [PubMed: PMC3045071]. S1PRs also play vital roles in vascular development, endothelial barrier maintenance, and cardiac rhythm modulation [UniProt]. In autoimmune conditions like multiple sclerosis and inflammatory bowel disease, S1P signaling facilitates the movement of inflammatory cells into target tissues [StatPearls: NBK542236]. Therapeutic modulators such as fingolimod and ozanimod act as functional antagonists by inducing receptor internalization and degradation, thereby sequestering lymphocytes in lymph nodes and reducing systemic inflammation [FDA: Zeposia Label]. Beyond immunology, S1PRs are involved in cancer cell survival and migration, making them targets of interest in oncology and fibrosis research [PubMed: PMC6061918]. Consequently, S1PR modulators have become a cornerstone in the management of relapsing forms of multiple sclerosis and moderate-to-severe ulcerative colitis [NIH: MedlinePlus].

Other names

S1P receptorEndothelial differentiation gene receptorEDG receptorS1PR1S1PR2S1PR3S1PR4S1PR5

S1P receptor modulators primarily function as functional antagonists; upon binding, they initially act as agonists but subsequently trigger receptor internalization and proteasomal degradation, which prevents lymphocyte egress from lymphoid tissues and reduces the infiltration of autoreactive cells into the central nervous system or gastrointestinal tract [FDA: Zeposia Label; PubMed: PMC3045071].